Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Intra-Uterine Contraceptive Devices Market Size Forecast: How Large Could The Market Become By 2030?
The intra-uterine contraceptive devices market size has experienced significant expansion in recent years. This market is set to increase from $3.45 billion in 2025 to $3.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. The historical growth of the market can be linked to heightened awareness concerning family planning and the adoption of contraception, government-driven population control and reproductive health initiatives, enhanced availability of gynecology clinics and maternal healthcare services, advancements in healthcare infrastructure in emerging regions, and an increasing inclination towards long-acting reversible contraceptive methods.
The intra-uterine contraceptive devices market size is projected to experience robust expansion over the coming years. This market is anticipated to reach $4. 78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6. 8%. This expansion during the forecast timeframe is attributable to several factors, including a heightened demand for minimally invasive and user-independent birth control methods, the proliferation of women-focused healthcare awareness initiatives, increased uptake of sophisticated hormonal and bioactive intrauterine systems, a global emphasis on reducing accidental pregnancies, and ongoing advancements in biocompatible and drug-releasing device innovations. Key trends expected within the forecast period encompass robotic assistance for intrauterine device insertions, automation in contraceptive manufacturing facilitated by Industry 4.0, IoT-driven intelligent medical device tracking and stock management, blockchain-powered traceability systems for the contraceptive supply chain, and mobile reproductive healthcare outreach services bolstered by electric mobility.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample_request?id=79103888&type=smp
Intra-Uterine Contraceptive Devices Market Growth Factors Supporting Long-Term Expansion
The expanding understanding of family planning is set to fuel the growth of the intra-uterine contraceptive devices market moving forward. This awareness encompasses the knowledge among individuals and couples about managing the number and spacing of their children using contraceptive methods. The increase in family planning awareness is primarily attributed to expanding public health education campaigns promoting reproductive health and informed contraceptive choices. Intra-uterine contraceptive devices significantly support family planning practices by offering long-term, reliable, and reversible contraception, aiding in effective pregnancy planning and birth spacing. For instance, in July 2025, a report from the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, noted that the global uptake of modern contraceptive methods reached approximately 874 million women in 2025. Moreover, an additional 70 million women are anticipated to gain access to family planning services by 2030, reflecting continued expansion in reproductive healthcare coverage and utilization. Thus, the escalating awareness surrounding family planning is a significant driver for the intra-uterine contraceptive device market’s expansion.
#Intra-Uterine Contraceptive Devices Market Segment Landscape And Growth Potential
The intra-uterine contraceptive devices market covered in this report is segmented –
1) By Product Type: Copper Intrauterine Devices, Hormonal Intrauterine Devices, Bioactive Intrauterine Devices
2) By Age Group: Fifteen To Twenty Four Years, Twenty Five To Thirty Four Years, Thirty Five To Forty Four Years, Above Forty Four Years
3) By Distribution Channel: Direct Sales, Online Retail, Wholesale
4) By Application: Contraception, Treatment Of Menorrhagia, Endometrial Protection
5) By End User: Hospitals, Gynecology Clinics, Community Healthcare, Other End Users
Subsegments:
1) By Copper Intrauterine Devices: Copper T Shaped Devices, Copper Multiload Devices, Copper Frameless Devices
2) By Hormonal Intrauterine Devices: Levonorgestrel Releasing Devices, Low Dose Hormonal Devices, High Dose Hormonal Devices
3) By Bioactive Intrauterine Devices: Silver Ion Releasing Devices, Gold Ion Coated Devices, Drug Eluting Bioactive Devices
Intra-Uterine Contraceptive Devices Market Industry Trends Shaping Future Revenue Growth
Major companies operating in the intra-uterine contraceptive devices market are concentrating on developing innovative products, such as hormone-free intrauterine systems, to enhance patient comfort and broaden non-hormonal contraceptive choices. A hormone-free intrauterine system is a long-acting birth control device placed in the uterus that prevents pregnancy through non-hormonal materials, typically copper, which create a spermicidal intrauterine environment. For instance, in February 2025, Sebela Pharmaceuticals Inc., a US-based pharmaceutical company specializing in gastroenterology and women’s health, announced the U. S. Food and Drug Administration approval of MIUDELLA. The product incorporates a flexible nitinol frame with a lower copper dose, while maintaining high contraceptive effectiveness, and is supported by a preloaded delivery system designed for ease of insertion. Its introduction is significant because it represents the first hormone-free intrauterine device approval in over four decades in the United States, highlighting renewed innovation in non-hormonal contraceptive technologies.
Intra-Uterine Contraceptive Devices Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the intra-uterine contraceptive devices market are AbbVie Inc., Bayer AG, Meril Life Sciences Pvt. Ltd., CooperSurgical Inc., Sebela Pharmaceuticals Inc., DKT International Inc., HRA Pharma Inc., Pregna International Limited, Egemen International, Zhejiang Daji Medical Instruments Co. Ltd., Medicines360, SMB Corporation of India, HLL Lifecare Limited, Injeflex Ind And Com Ltda, Gynocare Services Pvt Ltd., Aetos Pharma Pvt Ltd., Eurogine S. L., Mona Lisa N. V., Ocon Medical Ltd., Prosan International B. V.
Access The Complete Intra-Uterine Contraceptive Devices Market Report:
https://www.thebusinessresearchcompany.com/report/intra-uterine-contraceptive-devices-market-report
Intra-Uterine Contraceptive Devices Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the intra-uterine contraceptive devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intra-uterine contraceptive devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.